Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic MSC Transplantation for Pulp Necrosis
NCT04545307Phase 3Completed
- Sponsor
- Universidad Central de Venezuela
- Start
- Nov 2019
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic bone marrow-derived mesenchymal stromal cells in pulp necrosis, apical periodontitis (AP), sponsored by Universidad Central de Venezuela. Started Nov 2019; status: completed.
02
Drugs
allogeneic bone marrow-derived mesenchymal stromal cells
03
Conditions
pulp necrosisapical periodontitis (AP)
Beyond the preview
Go deeper on NCT04545307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04545307.